Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-ray attenuation by iodine is a physical phenomenon central to radiological imaging diagnostics, based on iodine's high atomic number (Z=53) and specific K-edge (33.2 keV). When X-rays of appropriate energy interact with iodine, the probability of photoelectric absorption increases sharply, resulting in enhanced local absorption (attenuation) of X-ray photons. This property is harnessed in iodinated contrast media to improve tissue contrast in imaging modalities like CT. The process is not a drug or molecular target, but a physical principle underlying the use of iodine compounds in clinical imaging agents. Though not a biological target, the process carries important safety considerations—including increased DNA damage and radiation dose to tissues exposed to iodinated contrast agents, potentially raising cancer risks[2][3][7].
Photoelectric effect (Iodine atoms absorb X-ray photons at energies near their K-shell binding energy, resulting in increased local attenuation and image contrast)[3][4][5][7]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray attenuation by iodine.